195 related articles for article (PubMed ID: 19103524)
21. Nod2 mutation in Crohn's disease potentiates NF-kappaB activity and IL-1beta processing.
Maeda S; Hsu LC; Liu H; Bankston LA; Iimura M; Kagnoff MF; Eckmann L; Karin M
Science; 2005 Feb; 307(5710):734-8. PubMed ID: 15692052
[TBL] [Abstract][Full Text] [Related]
22. NOD2/CARD15 genotype influences MDP-induced cytokine release and basal IL-12p40 levels in primary isolated peripheral blood monocytes.
Beynon V; Cotofana S; Brand S; Lohse P; Mair A; Wagner S; Mussack T; Ochsenkühn T; Folwaczny M; Folwaczny C; Glas J; Török HP
Inflamm Bowel Dis; 2008 Aug; 14(8):1033-40. PubMed ID: 18383179
[TBL] [Abstract][Full Text] [Related]
23. Nod2 improves barrier function of intestinal epithelial cells via enhancement of TLR responses.
Hiemstra IH; Bouma G; Geerts D; Kraal G; den Haan JM
Mol Immunol; 2012 Oct; 52(3-4):264-72. PubMed ID: 22750073
[TBL] [Abstract][Full Text] [Related]
24. Blau syndrome NOD2 mutations result in loss of NOD2 cross-regulatory function.
Mao L; Dhar A; Meng G; Fuss I; Montgomery-Recht K; Yang Z; Xu Q; Kitani A; Strober W
Front Immunol; 2022; 13():988862. PubMed ID: 36189261
[TBL] [Abstract][Full Text] [Related]
25. Crohn's disease patients homozygous for the 3020insC NOD2 mutation have a defective NOD2/TLR4 cross-tolerance to intestinal stimuli.
Kullberg BJ; Ferwerda G; de Jong DJ; Drenth JP; Joosten LA; Van der Meer JW; Netea MG
Immunology; 2008 Apr; 123(4):600-5. PubMed ID: 18028374
[TBL] [Abstract][Full Text] [Related]
26. Reduced alpha-defensin expression is associated with inflammation and not NOD2 mutation status in ileal Crohn's disease.
Simms LA; Doecke JD; Walsh MD; Huang N; Fowler EV; Radford-Smith GL
Gut; 2008 Jul; 57(7):903-10. PubMed ID: 18305068
[TBL] [Abstract][Full Text] [Related]
27. Normal responses to specific NOD1-activating peptidoglycan agonists in the presence of the NOD2 frameshift and other mutations in Crohn's disease.
van Heel DA; Hunt KA; Ghosh S; Hervé M; Playford RJ
Eur J Immunol; 2006 Jun; 36(6):1629-35. PubMed ID: 16637007
[TBL] [Abstract][Full Text] [Related]
28. [NOD2/CARD15 mutations and genotype-phenotype correlations in patients with Crohn's disease. Hungarian multicenter study].
Lakatos L; Lakatos PL; Willheim-Polli C; Reinisch W; Ferenci P; Tulassay Z; Molnár T; Kovács A; Papp J; Szalay F;
Orv Hetil; 2004 Jul; 145(27):1403-11. PubMed ID: 15320482
[TBL] [Abstract][Full Text] [Related]
29. Cellular and molecular mechanisms underlying NOD2 risk-associated polymorphisms in Crohn's disease.
Strober W; Asano N; Fuss I; Kitani A; Watanabe T
Immunol Rev; 2014 Jul; 260(1):249-60. PubMed ID: 24942694
[TBL] [Abstract][Full Text] [Related]
30. Hyperexpression of NOD2 in intestinal mast cells of Crohn's disease patients: preferential expression of inflammatory cell-recruiting molecules via NOD2 in mast cells.
Okumura S; Yuki K; Kobayashi R; Okamura S; Ohmori K; Saito H; Ra C; Okayama Y
Clin Immunol; 2009 Feb; 130(2):175-85. PubMed ID: 18938111
[TBL] [Abstract][Full Text] [Related]
31. The molecular basis of NOD2 susceptibility mutations in Crohn's disease.
Strober W; Kitani A; Fuss I; Asano N; Watanabe T
Mucosal Immunol; 2008 Nov; 1 Suppl 1(0 1):S5-9. PubMed ID: 19079230
[TBL] [Abstract][Full Text] [Related]
32. CARD15 variants determine a disturbed early response of monocytes to adherent-invasive Escherichia coli strain LF82 in Crohn's disease.
Peeters H; Bogaert S; Laukens D; Rottiers P; De Keyser F; Darfeuille-Michaud A; Glasser AL; Elewaut D; De Vos M
Int J Immunogenet; 2007 Jun; 34(3):181-91. PubMed ID: 17504508
[TBL] [Abstract][Full Text] [Related]
33. Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease.
Inohara N; Ogura Y; Fontalba A; Gutierrez O; Pons F; Crespo J; Fukase K; Inamura S; Kusumoto S; Hashimoto M; Foster SJ; Moran AP; Fernandez-Luna JL; Nuñez G
J Biol Chem; 2003 Feb; 278(8):5509-12. PubMed ID: 12514169
[TBL] [Abstract][Full Text] [Related]
34. Functional interaction of CARD15/NOD2 and Crohn's disease-associated TNFalpha polymorphisms.
Linderson Y; Bresso F; Buentke E; Pettersson S; D'Amato M
Int J Colorectal Dis; 2005 Jul; 20(4):305-11. PubMed ID: 15800781
[TBL] [Abstract][Full Text] [Related]
35. Human umbilical cord blood mesenchymal stem cells reduce colitis in mice by activating NOD2 signaling to COX2.
Kim HS; Shin TH; Lee BC; Yu KR; Seo Y; Lee S; Seo MS; Hong IS; Choi SW; Seo KW; Núñez G; Park JH; Kang KS
Gastroenterology; 2013 Dec; 145(6):1392-403.e1-8. PubMed ID: 23973922
[TBL] [Abstract][Full Text] [Related]
36. Toll-like receptor-induced granulocyte-macrophage colony-stimulating factor secretion is impaired in Crohn's disease by nucleotide oligomerization domain 2-dependent and -independent pathways.
Brosbøl-Ravnborg A; Hvas CL; Agnholt J; Dahlerup JF; Vind I; Till A; Rosenstiel P; Höllsberg P
Clin Exp Immunol; 2009 Mar; 155(3):487-95. PubMed ID: 19094116
[TBL] [Abstract][Full Text] [Related]
37. IL-32 synergizes with nucleotide oligomerization domain (NOD) 1 and NOD2 ligands for IL-1beta and IL-6 production through a caspase 1-dependent mechanism.
Netea MG; Azam T; Ferwerda G; Girardin SE; Walsh M; Park JS; Abraham E; Kim JM; Yoon DY; Dinarello CA; Kim SH
Proc Natl Acad Sci U S A; 2005 Nov; 102(45):16309-14. PubMed ID: 16260731
[TBL] [Abstract][Full Text] [Related]
38. MIP-3α expression in macrophages is NOD dependent.
Hausmann M; Zeitler C; Weber A; Krebs M; Kellermeier S; Rosenstiel P; de Vallière C; Kosovac K; Fried M; Holler E; Rogler G
Digestion; 2012; 85(3):192-201. PubMed ID: 22286692
[TBL] [Abstract][Full Text] [Related]
39. Direct and indirect induction by 1,25-dihydroxyvitamin D3 of the NOD2/CARD15-defensin beta2 innate immune pathway defective in Crohn disease.
Wang TT; Dabbas B; Laperriere D; Bitton AJ; Soualhine H; Tavera-Mendoza LE; Dionne S; Servant MJ; Bitton A; Seidman EG; Mader S; Behr MA; White JH
J Biol Chem; 2010 Jan; 285(4):2227-31. PubMed ID: 19948723
[TBL] [Abstract][Full Text] [Related]
40. Muramyl dipeptide responsive pathways in Crohn's disease: from NOD2 and beyond.
Salem M; Seidelin JB; Rogler G; Nielsen OH
Cell Mol Life Sci; 2013 Sep; 70(18):3391-404. PubMed ID: 23275943
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
